Retinoic Acid Modulates PTGDR Promoter Activity

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Vitamin A metabolites, including retinoic acid (RA), are implicated in allergic disease development.
• The prostaglandin receptor PTGDR is a candidate gene for allergy and asthma, potentially linked to RA via the prostaglandin pathway.

Purpose of the Study:

• To investigate the effect of retinoic acid (RA) on the activation of the PTGDR gene promoter.
• To explore the role of PTGDR in the context of allergic diseases and RA signaling.

Main Methods:

• A549 lung epithelial cells were transfected with PTGDR promoter variants and treated with all-trans RA (ATRA).
• Luciferase assays and real-time quantitative PCR were used to measure gene expression and promoter activity.
• In silico analysis identified potential RA response elements in the PTGDR promoter.

Main Results:

• ATRA treatment significantly increased PTGDR promoter activity (P<.001).
• Expression of CYP26A1 and RARB genes increased 12-fold and 4-fold, respectively, after ATRA treatment.
• In silico analysis confirmed the presence of RA response elements within the PTGDR promoter region.

Conclusions:

• Retinoic acid (RA) modulates PTGDR gene promoter activity.
• The effectiveness of RA and potential new PTGDR-targeting therapies may depend on the genetic background of allergic asthma patients.